Delivering better medicines to children: Need for better integration between the science, the policy, and the practice

Pediatric Drugs

Volumn 11, Issue 1, 2009, Pages 41-44

  Gazarian, Madlen ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Children; Drug utilisation; Pharmacology; Prescribing; Research and development

Indexed keywords

AUSTRALIA; CHILD HEALTH CARE; CONFERENCE PAPER; DRUG USE; EUROPEAN UNION; HEALTH CARE ACCESS; HEALTH CARE POLICY; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

AUSTRALIA; CHILD; CHILD HEALTH SERVICES; HEALTH PRIORITIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; PHARMACEUTICAL PREPARATIONS;

EID: 58149345829     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/0148581-200911010-00014     Document Type: Conference Paper

References (23)

1. Ward RM, Kauffman R. Future of pediatric therapeutics: reauthorization of BPCA and PREA. Clin Pharmacol Ther 2007; 81 (4): 477-9
2. MacLeod S, Peterson R, Wang Y, et al. Challenges in international pediatric pharmacology: a milestone meeting in Shanghai. Pediatr Drugs 2007; 9 (4): 215-8
3. Stephenson T. "bonne anne", "gutes neues jahr"? Will 2007 be a "happy new year" for children's medicines in Europe? Arch Dis Child 2007; 92: 661-3
4. Permanand G, Mossialos E, McKee M. The EU's new paediatric medicines legislation: serving children's needs? Arch Dis Child 2007; 92: 808-11
5. Hoppu K. Paediatric clinical pharmacology: at the beginning of a new era. Eur J Clin Pharmacol 2008; 64 (2): 201-5
6. WHO. Make medicines child size (2007) [online]. Available from URL: http://www.who.int/childmedicines/en/ [Accessed 2008 Dec 9]
7. Schreiner M. Paediatric clinical trials: redressing the imbalance. Nat Rev Drug Discov 2003; 2: 949-61
8. Li JS, Eisenstein EL, Grabowski HG, et al. Economic return of clinical trials performed under the pediatric exclusivity program. JAMA 2007; 297 (5): 480-8
9. Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labelling: improving the safety and efficacy of pediatric therapies. JAMA 2003; 290 (7): 905-11
10. Grieve J, Tordoff J, Reith D, et al. Effect of the pediatric exclusivity provision on children's access to medicines. Br J Clin Pharmacol 2005; 59 (6): 730-5
11. Lenfant C. Clinical research to clinical practice: lost in translation? N Engl J Med 2003; 349: 868-74
12. Gazarian M. EBM in practice: paediatrics. Med J Aust 2001; 174: 586-7
13. Gazarian M. Delivering better medicines to children: need for a better integrated approach. International Paediatric Pharmacology Symposium, 15th World Con-gress of Pharmacology, International Challenges in Paediatric Pharmacology; 2006 Jun 29-30; Shanghai
14. Gazarian M. QUM and children: on the cusp of a brand new era [abstract no. 203]. National Medicines Symposium 2008. QUM-what does it really mean for you? The science the policy and the practice; 2008 May 14-16; Canberra (ACT): 75
15. Hogerzeil HV. The concept of essential medicines: lessons for rich countries. BMJ 2004; 329: 1169-72
16. Australian Government Department of Health and Ageing. The national medicines policy document [online]. Available from URL: http://www.health.gov. au/internet/main/publishing.nsf/Content/nmp-objectives-policy.htm [Accessed 2008 Dec 8]
17. Australian Government Department of Health and Ageing. The national strategy for quality use of medicines (executive summary) [online]. Available from URL: http://www.health.gov.au/internet/main/publishing.nsf/Content/ 4CCAC8550BA36A52CA256F1800468A6E/$File/execsumbro.pdf [Accessed 2008 Dec 8]
18. National Prescribing Service Limited [online]. Available from URL: http://www.nps.org.au/about_us [Accessed 2008 Dec 8]
19. National Prescribing Service Limited. Annual report 2006-7 [online]. Available from URL: http://www.nps.org.au/_data/assets/pdf_file/0005/26861/ nps_annual_report_2007.pdf [Accessed 2008 Dec 8]
20. Gazarian M, Kelly M, McPhee JR, et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust 2006; 185: 544-8
21. Gazarian M. Evaluating appropriateness of off-label medicines use: implications for policy, practice and research [abstract]. The IXth World Conference on Clinical Pharmacology and Therapeutics; 2008 Jul 27-Aug 1; Quebec City (QC)
22. Gazarian M. Off-label use of medicines in the paediatric population: recommendations for assessing appropriateness. Discussion paper for consultation, 7 May 2007. In: WHO. Expert consultation on essential medicines for children, 9-13 July 2007, Geneva [online]. Available from URL: http://archives.who.int/eml/expcom/children/INDEX_children_07-2.htm [Accessed 2008 Dec 11]
23. WHO. WHO Model Lists of Essential Medicines [online]. Available from URL: http://www.who.int/medicines/publications/essentialmedicines/en/index.html [Accessed 2008 Dec 19]